Retinal Artery Occlusion (BRAO & CRAO)

If you arrive within 4.5 hours of symptom onset and meet specific criteria, stroke teams may consider intravenous thrombolysis following standard stroke protocols; at selected centers, endovascular options may be considered in narrowly defined scenarios, typically within about 6 hours. Both approaches require rapid assessment and shared decision-making given limited evidence in eye stroke compared with brain stroke.

Some centers may offer hyperbaric oxygen therapy very early after vision loss to improve oxygen delivery to injured retinal tissue. It is not standard of care and is considered a weak option that may be used when available at experienced facilities.

Historically used approaches such as ocular massage, pressure-lowering drops, and anterior chamber paracentesis have uncertain benefit and are not routinely recommended. They should never delay immediate transfer to a stroke-capable center for definitive evaluation and management.

Systemic therapy focuses on individualized vascular prevention with your other doctors, typically antiplatelet therapy after non-arteritic RAO and anticoagulation only for specific cardioembolic indications. In the eye, anti-VEGF injections may be used later if abnormal new vessels develop or to reduce the risk of neovascular glaucoma.

Weeks to months after the initial event, some patients develop abnormal blood vessel growth in the retina, iris, or angle. We use panretinal photocoagulation and/or intraocular injections to prevent or treat these complications before they cause additional vision loss.

Controlling blood pressure, cholesterol, and diabetes, quitting smoking, and using prescribed vascular medications are essential to protect vision and reduce stroke and heart attack risk. We work closely with cardiology, neurology, and primary care to optimize your plan.

For patients with lasting vision loss, we refer to low vision specialists for training, assistive devices, and strategies to maintain independence. Structured rehabilitation can make a major difference in daily functioning, particularly when CRAO recovery is limited.

BRAO patients often retain some vision and may see modest improvement over months depending on the area involved. CRAO typically causes severe, permanent loss, though a minority may improve with very early stroke-pathway treatment or when a cilioretinal artery supplies the fovea.

Yes, RAO is considered an acute ischemic stroke of the retina and requires evaluation through established stroke pathways. This is why we coordinate immediately with stroke centers and neurologists.

Treat sudden vision loss as a medical emergency and call 911 or go to a stroke-capable emergency room immediately. If possible, also call our office so we can coordinate care, but never delay emergency treatment to reach us first.

The most critical window is within 90 minutes to 4.5 hours for potential emergency medications, and some centers consider endovascular options within about 6 hours in selected cases. Even if time windows have passed, urgent evaluation remains essential because vascular risk is highest in the first days to weeks.

Yes. Control blood pressure, cholesterol, and diabetes aggressively, follow antiplatelet or anticoagulation plans when indicated, quit smoking, and exercise regularly. Coordinated care with your medical team can reduce risk substantially.

Coordinated care is standard after RAO. You will typically see cardiology, neurology, and your primary care physician to address causes and prevent future events.

Frequency is personalized and higher early on to monitor for neovascularization and pressure changes. If no complications develop, visits can be spaced out, but lifelong monitoring remains important.

It is uncommon but possible, particularly in severe cardiovascular disease, giant cell arteritis, or certain blood disorders. Aggressive risk factor control and regular monitoring of both eyes help reduce that risk.

Yes, the risk of ischemic stroke is highest in the first 7–14 days after RAO and remains elevated thereafter. Immediate and ongoing cardiovascular care is a critical part of your treatment plan.

Most patients can gradually resume normal activities with safety modifications based on remaining vision and overall health. Driving requires formal evaluation, and many with significant vision loss may not meet legal standards.

Absolutely. Lifestyle improvements remain among the most effective ways to reduce the risk of future vascular events and protect your remaining vision.

Research continues into emergency therapies, neuroprotection, and regenerative strategies for RAO. When appropriate, we can discuss clinical trials that may be available to you.

With structured vision rehabilitation, assistive technology, and emotional support, many patients adapt well and maintain fulfilling lives. Early referral and ongoing support are key.

Yes, we connect patients with local and national organizations and online communities for education, peer support, and practical resources. These networks can make day-to-day life easier and more independent.

RAO itself isn’t directly inherited, but shared cardiovascular risks are common in families. Encourage regular eye exams and healthy habits, and seek care promptly if symptoms occur.

Artery occlusion blocks blood flow into the retina and typically causes more sudden, severe vision loss with higher stroke risk. Vein occlusion blocks drainage and often has different complications and outcomes, but both require expert retina care.